JP2025509432A5 - - Google Patents
Info
- Publication number
- JP2025509432A5 JP2025509432A5 JP2024553843A JP2024553843A JP2025509432A5 JP 2025509432 A5 JP2025509432 A5 JP 2025509432A5 JP 2024553843 A JP2024553843 A JP 2024553843A JP 2024553843 A JP2024553843 A JP 2024553843A JP 2025509432 A5 JP2025509432 A5 JP 2025509432A5
- Authority
- JP
- Japan
- Prior art keywords
- disorder
- therapeutic combination
- receptor agonist
- receptor
- combination according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263318369P | 2022-03-09 | 2022-03-09 | |
| US63/318,369 | 2022-03-09 | ||
| PCT/US2023/014926 WO2023172701A2 (en) | 2022-03-09 | 2023-03-09 | Therapeutic combinations, compositions, and methods for designing and producing entactogenic mindstates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025509432A JP2025509432A (ja) | 2025-04-11 |
| JP2025509432A5 true JP2025509432A5 (https=) | 2026-03-17 |
Family
ID=87935763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024553843A Pending JP2025509432A (ja) | 2022-03-09 | 2023-03-09 | エンタクトゲン心理状態を設計および生成するための治療的組み合わせ、組成物、および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250177354A1 (https=) |
| EP (1) | EP4489649A2 (https=) |
| JP (1) | JP2025509432A (https=) |
| KR (1) | KR20250011101A (https=) |
| CN (1) | CN119497589A (https=) |
| AU (1) | AU2023232712A1 (https=) |
| CA (1) | CA3245622A1 (https=) |
| CR (1) | CR20240417A (https=) |
| IL (1) | IL315512A (https=) |
| MX (1) | MX2024011043A (https=) |
| WO (1) | WO2023172701A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250145285A (ko) * | 2024-03-28 | 2025-10-13 | 건국대학교 글로컬산학협력단 | 릴메니딘을 포함하는 정서장애의 예방, 개선 또는 치료용 조성물 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014004676A1 (en) * | 2012-06-26 | 2014-01-03 | Ironwood Pharmaceuticals, Inc. | Use of faah inhibitors as neuroprotective agents in the cns |
-
2023
- 2023-03-09 AU AU2023232712A patent/AU2023232712A1/en active Pending
- 2023-03-09 JP JP2024553843A patent/JP2025509432A/ja active Pending
- 2023-03-09 US US18/845,088 patent/US20250177354A1/en active Pending
- 2023-03-09 KR KR1020247033694A patent/KR20250011101A/ko active Pending
- 2023-03-09 CN CN202380038385.8A patent/CN119497589A/zh active Pending
- 2023-03-09 CR CR20240417A patent/CR20240417A/es unknown
- 2023-03-09 WO PCT/US2023/014926 patent/WO2023172701A2/en not_active Ceased
- 2023-03-09 CA CA3245622A patent/CA3245622A1/en active Pending
- 2023-03-09 IL IL315512A patent/IL315512A/en unknown
- 2023-03-09 EP EP23767488.2A patent/EP4489649A2/en active Pending
-
2024
- 2024-09-09 MX MX2024011043A patent/MX2024011043A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2317817C2 (ru) | Применение (1s,2r) энантиомера милнаципрана для получения лекарственного средства | |
| Wichniak et al. | Sleep and antidepressant treatment | |
| KR100935277B1 (ko) | 고선택성 노르에피네프린 재흡수 억제제 및 그의 이용 방법 | |
| JP2021519271A5 (https=) | ||
| CN117693336A (zh) | 抑郁症的治疗 | |
| JP2021519267A5 (https=) | ||
| JP7245509B2 (ja) | 吃音を治療するための融合ベンズアゼピン | |
| JP2008531714A (ja) | 不安障害の治療用及び／又は予防用の医薬組成物 | |
| JP2009531435A (ja) | うつ病の治療用の新規な治療組み合わせ | |
| JP2012526832A5 (https=) | ||
| JP2025509432A5 (https=) | ||
| CA3104811A1 (en) | Composition comprising pramipexole and nk1-antagonists for treating depression | |
| Karabin et al. | The monoamine theory of depression as a target to effective pharmacotherapy | |
| JP2009500420A (ja) | エスゾピクロン及びｏ−デスメチルベンラファキシンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法 | |
| JP2009500421A (ja) | エスゾピクロン及び抗うつ薬の組み合わせ | |
| JP2025501411A5 (https=) | ||
| Huynh et al. | Fibromyalgia: diagnosis and management for the primary healthcare provider | |
| CN104884060A (zh) | 治疗方案 | |
| CA2460348A1 (en) | Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites | |
| EP4547250A1 (en) | Methods and compositions relating to controlling psychedelic effects with serotonin receptor modulators | |
| US20060217394A1 (en) | Treatment of anhedonia | |
| Elia | Side effects of antidepressants | |
| WO2009147831A1 (ja) | 精神障害の治療方法および治療用医薬組成物 | |
| JP2023008912A5 (https=) | ||
| Rizek et al. | Management of Advanced Parkinson’s Disease |